日本語 
Pharma
Curatis Holding AG has signed an exclusive licensing and development agreement with Japanese pharma company Neupharma for corticorelin, also known as C-PTBE-01. The research examines how to treat peritumoral brain…
FUJIFILM and argenx Extend Collaboration to U.S. Operations
FUJIFILM Biotechnologies, a top global CDMO for biologics and vaccines, is expanding…
Rohto Pharma Builds Global Platform with Dynamics 365
Hitachi Solutions, Ltd. has implemented Microsoft Dynamics 365 at Rohto Pharmaceutical Co.,…
Hitachi and KSK Team Up on Pharma Delivery Digitalization
KSK Corporation and Hitachi, Ltd. have begun a collaborative creation project to…
Eisai seeks FDA approval for LEQEMBI Subcutaneous dose
Eisai Co., Ltd. and Biogen Inc. have started a rolling supplemental Biologics…
MEDIPAL and JCR Ink Global Deal for GM2 Drug JR-479
MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the two…
Eisai’s Tazemetostat Approved as Orphan Drug in Japan
Eisai Co., Ltd. announced that it has received orphan drug designation for…
Austria and Germany First in EU to Launch LEQEMBI
Eisai Co., Ltd. and Biogen Inc. shared that LEQEMBI (lecanemab), an anti-amyloid…
JDSC launches Smart Factory for pharma manufacturing
JDSC Co., Ltd. has launched a smart factory project to advance pharmaceutical…
English